Cargando…
CRMP2 is necessary for Neurofibromatosis type 1 related pain
Neurofibromatosis type 1 (NF1) is one of the most common genetic diseases, affecting roughly 1 in 3000 individuals. As a multisystem disorder, it affects cognitive development, as well as bone, nerve and muscle constitution. Peripheral neuropathy in NF1 constitutes a potentially severe clinical comp...
Autores principales: | Moutal, Aubin, Cai, Song, Luo, Shizhen, Voisin, Raphaëlle, Khanna, Rajesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972793/ https://www.ncbi.nlm.nih.gov/pubmed/28837387 http://dx.doi.org/10.1080/19336950.2017.1370524 |
Ejemplares similares
-
Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain
por: Moutal, Aubin, et al.
Publicado: (2018) -
Activity of T-type calcium channels is independent of CRMP2 in sensory neurons
por: Cai, Song, et al.
Publicado: (2019) -
Evaluation of edonerpic maleate as a CRMP2 inhibitor for pain relief
por: Moutal, Aubin, et al.
Publicado: (2019) -
Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides
por: Moutal, Aubin, et al.
Publicado: (2015) -
Differential expression of Cdk5-phosphorylated CRMP2 following a spared nerve injury
por: Moutal, Aubin, et al.
Publicado: (2020)